ACXP Acurx Pharmaceuticals0.75+0.44 (+144.3%)
Premarket Decliner
ACXP Acurx Pharmaceuticals4.75+0.12+2.6%
Premarket:3.88-0.87 (-18.3%)
Acurx Announces Positive Comparative Microbiology and Microbiome Data for Ibezapolstat from Phase 2b Clinical Trial in CDI Patients
PRNewswireWed, 17-Jan 7:01 AM
ACXP Acurx Pharmaceuticals3.26-0.53 (-13.9%)
ACXP Acurx Pharmaceuticals3.61-1.46 (-28.8%)
ACXP Acurx Pharmaceuticals4.85+0.77 (+18.9%)
ACXP Acurx Pharmaceuticals6.17+2.43 (+65.0%)